App DescriptionThe American College of Cardiologyâ€™s AnticoagEvaluator is an easy and fast way to assess stroke and bleeding risk and the benefits and risks of antithrombotic therapy in patients with chronic atrial fibrillation.
â€¢ A combination risk calculator tool that uses CHADS2, CHA2DS2-VASc, and HAS-BLED
â€¢ Users can enter patient characteristics at the point of care and get individualized annual risk of ischemic stroke and thromboembolism with concurrent annual risk of major bleed
â€¢ Compare antithrombotic therapy options based on clinical trials (ACTIVE-A, RE-LY, ROCKET-AF, ARISTOTLE)
This app is adapted from a web tool created by Peter Loewen, B.Sc.(Pharm), ACPR, Pharm.D., FCSHP and can be viewed at http://www.sparctool.com/
March 06, 2013 Initial Release